Cargando…

Crystallization and crystallographic studies of kallistatin

Kallistatin is a serine protease inhibitor (serpin) which specifically inhibits human tissue kallikrein; however, its inhibitory activity is inhibited by heparin. In order to elucidate the underlying mechanism, recombinant human kallistatin was prepared in Escherichia coli and the protein was crysta...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Fang, Zhou, Aiwu, Wei, Zhenquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Union of Crystallography 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4555919/
https://www.ncbi.nlm.nih.gov/pubmed/26323298
http://dx.doi.org/10.1107/S2053230X15012893
_version_ 1782388271940108288
author Lin, Fang
Zhou, Aiwu
Wei, Zhenquan
author_facet Lin, Fang
Zhou, Aiwu
Wei, Zhenquan
author_sort Lin, Fang
collection PubMed
description Kallistatin is a serine protease inhibitor (serpin) which specifically inhibits human tissue kallikrein; however, its inhibitory activity is inhibited by heparin. In order to elucidate the underlying mechanism, recombinant human kallistatin was prepared in Escherichia coli and the protein was crystallized by the sitting-drop vapour-diffusion method. X-ray diffraction data were collected to 1.9 Å resolution. The crystals were found to belong to space group P6(1), with unit-cell parameters a = 113.51, b = 113.51, c = 76.17 Å. Initial analysis indicated that the crystallized kallistatin was in a relaxed conformation, with its reactive-centre loop inserted in the central β-sheet.
format Online
Article
Text
id pubmed-4555919
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher International Union of Crystallography
record_format MEDLINE/PubMed
spelling pubmed-45559192015-09-22 Crystallization and crystallographic studies of kallistatin Lin, Fang Zhou, Aiwu Wei, Zhenquan Acta Crystallogr F Struct Biol Commun Research Communications Kallistatin is a serine protease inhibitor (serpin) which specifically inhibits human tissue kallikrein; however, its inhibitory activity is inhibited by heparin. In order to elucidate the underlying mechanism, recombinant human kallistatin was prepared in Escherichia coli and the protein was crystallized by the sitting-drop vapour-diffusion method. X-ray diffraction data were collected to 1.9 Å resolution. The crystals were found to belong to space group P6(1), with unit-cell parameters a = 113.51, b = 113.51, c = 76.17 Å. Initial analysis indicated that the crystallized kallistatin was in a relaxed conformation, with its reactive-centre loop inserted in the central β-sheet. International Union of Crystallography 2015-08-25 /pmc/articles/PMC4555919/ /pubmed/26323298 http://dx.doi.org/10.1107/S2053230X15012893 Text en © Lin et al. 2015 http://creativecommons.org/licenses/by/2.0/uk/ This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.
spellingShingle Research Communications
Lin, Fang
Zhou, Aiwu
Wei, Zhenquan
Crystallization and crystallographic studies of kallistatin
title Crystallization and crystallographic studies of kallistatin
title_full Crystallization and crystallographic studies of kallistatin
title_fullStr Crystallization and crystallographic studies of kallistatin
title_full_unstemmed Crystallization and crystallographic studies of kallistatin
title_short Crystallization and crystallographic studies of kallistatin
title_sort crystallization and crystallographic studies of kallistatin
topic Research Communications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4555919/
https://www.ncbi.nlm.nih.gov/pubmed/26323298
http://dx.doi.org/10.1107/S2053230X15012893
work_keys_str_mv AT linfang crystallizationandcrystallographicstudiesofkallistatin
AT zhouaiwu crystallizationandcrystallographicstudiesofkallistatin
AT weizhenquan crystallizationandcrystallographicstudiesofkallistatin